A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
This study has been completed.
Study NCT00810147
Information provided by Bristol-Myers Squibb
First Received on December 16, 2008.
Last Updated on January 24, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
